Skip to main content
. Author manuscript; available in PMC: 2018 Sep 25.
Published in final edited form as: N Engl J Med. 2018 Sep 26;379(15):1403–1415. doi: 10.1056/NEJMoa1800474

Table 4. Genotypic drug profile predictions of pan-susceptibility.

Prediction Genotypic drug profile Number predicted to have drug profile Number predicted to have drug profile that are phenotypic ally pansusceptible (%) Sensitivity % Specificity % PPV % NPV % Predictions made %
Inh Rif Emb Pza
(a) Predicted pan-susceptible S S S S 4,037 3952 (97.9)
(b) Predicted pansusceptible after inferring that 'U' mutations are consistent with susceptibility in this context S S S U 11 11 (100)
S S U S 410 399 (97.3)
S S U U 2 2 (100)
S U S S 93 88 (94.6)
S U U S 29 29 (100)
Total 4,582 4481 (97.8)
(c) Predicted to have some phenotypic resistance R S R or S 397 18 (4.5)
S At least one R, no U or F 158 36 (22.8)
R R R or S 1273 1 (0.1)
Total 1828 55 (3.0)
95.4 98.6 97.0 97.9 78.0
94.6 98.8 97.0 97.8 85.1
No prediction made (drug profile prediction incomplete) U S or U 150 126 (84.0)
At least one F, no R 280 240 (85.7)
At least one R and U, no F 499 6 (1.2)
At least one R and F, no U 159 3 (1.9)
At least one R, U, and F 18 0 (0.0)
Total 1106 375 (33.9)